Tag - Stephanie Davis

Markets

Analysts downgrade Accolade on lower 2023 guidance; loss of client

Analysts for SVB Securities and BTIG downgraded Accolade (NASDAQ:ACCD) after the company reduced the growth of its fiscal 2023 guidance to 15% year-over-year from 25% and the loss of Comcast as Accolade’s flagship...

April 29, 2022

Markets

SVB Leerink ups NextGen Healthcare PT to $21 from $14

SVB Leerink raised its price target for NextGen Healthcare (NASDAQ:NXGN) to $21 from $14, citing unaudited preliminary fiscal third quarter results ended Dec. 31, 2020 that beat Street estimates and higher fiscal 2021...

January 13, 2021

Tag - Stephanie Davis

Analysts downgrade Accolade on lower 2023 guidance; loss of client

SVB Leerink ups NextGen Healthcare PT to $21 from $14

General

More